AMINOSYN II 3.5% M Drug Patent Profile
✉ Email this page to a colleague
When do Aminosyn Ii 3.5% M patents expire, and when can generic versions of Aminosyn Ii 3.5% M launch?
Aminosyn Ii 3.5% M is a drug marketed by Icu Medical Inc, Abbott, and Hospira Inc. and is included in five NDAs.
The generic ingredient in AMINOSYN II 3.5% M is amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium acetate; potassium acetate; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMINOSYN II 3.5% M?
- What are the global sales for AMINOSYN II 3.5% M?
- What is Average Wholesale Price for AMINOSYN II 3.5% M?
Summary for AMINOSYN II 3.5% M
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
DailyMed Link: | AMINOSYN II 3.5% M at DailyMed |